| Financial Year |
March 31 2023 |
| Monetary Funds |
385,662,885.45 |
| Held-for-trading Financial Assets |
47,820,127.55 |
| Notes Receivable |
155,075,870.15 |
| Accounts Receivable |
127,672,479.99 |
| Advances to Suppliers |
11,559,380.35 |
| Other Receivables |
70,986,107.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,053,372,803.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,280,471.48 |
| Other Current Assets |
174,874,674.34 |
| Total Current Assets |
3,351,177,673.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
843,073.21 |
| Long-term Equity Investment |
104,097,236.26 |
| Investment Properties |
-- |
| Fixed Assetes |
151,810,462.00 |
| Under-construction Projects |
19,716,823.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,424,372.42 |
| R&D expenses |
-- |
| Goodwill |
384,476,471.78 |
| Long-Term Deferred and Prepaid Expenses |
47,812,967.67 |
| Deferred Income Tax Assets |
31,311,415.20 |
| Other Non-Current Assets |
109,349,968.21 |
| Sub-Total of Non-Current Assets |
1,071,174,907.47 |
| Total Assets |
4,422,352,581.14 |
| Short-Term Loans |
418,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
374,374,114.99 |
| Accounts Payable |
612,353,460.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,384,486.60 |
| Taxes Payable |
31,965,831.82 |
| Interest Payable |
861,875.00 |
| Dividend Payable |
3,020,000.00 |
| Other payables |
408,109,267.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,808,115.98 |
| Other Current Liabilities |
44,203,953.97 |
| Sub-Total of Current Liabilities |
3,249,814,758.44 |
| Long-term Loans |
6,024,999.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
57,210,966.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
49,135,308.91 |
| Deferred Income Tax Liabilities |
2,861,931.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
233,308,090.02 |
| Total Liabilities |
3,483,122,848.46 |
| Paid-In Capital(Or Share Stock) |
734,725,698.00 |
| Capital Surplus |
1,462,998,302.84 |
| Surplus Reserve |
17,897,661.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,358,702,546.20 |
| Minority Stockholder's Interest |
82,310,616.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
856,919,116.17 |
| Owner's Equity（Stockholder's Equity） |
939,229,732.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,422,352,581.14 |
